Key result
A comprehensive coronary function test protocol was feasible and safe in patients with ANOCA, identifying isolated microvascular angina in 25% and isolated vasospastic angina in 40%.
Why the study?
Coronary vasomotion disorders cause significant morbidity in non-obstructive coronary artery disease, but assessment protocols in clinical practice are seldom standardized and may be difficult to implement.
Is a comprehensive coronary function test protocol safe and feasible for assessing coronary vasomotion disorders in patients with ANOCA?
Observational (n=20)
No
Is a comprehensive coronary function test protocol safe and feasible for assessing coronary vasomotion disorders in patients with ANOCA?
Answers are grounded in this paper and cite their sources.
A standardized invasive coronary function test protocol is safe, feasible, and provides actionable diagnostic information that guides pharmacological therapy in patients with angina and non-obstructive coronary artery disease.
Coronary vasomotion disorders (CVDs), including microvascular angina (MVA) and vasospastic angina (VSA), account for significant morbidity among patients with non-obstructive coronary artery disease (NOCAD). However, protocols for CVD assessment in clinical practice are seldom standardized and may be difficult to implement. To assess the safety and feasibility of a comprehensive coronary function test (CFT) protocol for assessment of CVD and the prevalence of different phenotypes of CVD in patients with angina and NOCAD (ANOCA). Patients with persistent angina referred for invasive coronary angiogram and found to have NOCAD were prospectively recruited and underwent a CFT. Functional parameters (fractional flow reserve, coronary flow reserve and index of myocardial resistance) and coronary vasoreactivity were assessed in all patients. Of the 20 patients included, the mean age was 63±13 years and 50% were females. Most patients had persistent typical angina and evidence of ischemia in noninvasive tests (75%). The CFT was successfully performed in all subjects without serious complications. Isolated MVA was found in 25%, isolated VSA in 40%, both MVA and VSA in 10% and noncardiac chest pain in 25% of patients. Antianginal therapy was modified after the results of CFT in 70% of patients. A coronary function test was feasible and safe in a cohort of patients with ANOCA. CVD were prevalent in this selected group of patients, and some presented mixed CVD phenotypes. CFT may provide a definitive diagnosis in patients with persistent angina and prompt the stratification of pharmacological therapy. Os distúrbios vasomotores coronários (DVC), incluindo a angina microvascular (AMV) e a angina vasospástica (AV), resultam em morbilidade significativa para doentes sem doença coronária obstrutiva (DCO). Contudo, os protocolos de avaliação dos DVC na prática clínica variam substancialmente e poderão não ser de fácil implantação. Testar a segurança e exequibilidade de um protocolo de estudo da função coronária (EFC) e avaliar a prevalência de diferentes fenótipos de DVC em doentes com angina mas sem DCO (ANOCA). Doentes referenciados para angiografia coronária invasiva (ACI) com angina persistente e sem evidência de DCO foram prospetivamente incluídos e submetidos a EFC. Foi realizada avaliação de parâmetros funcionais (fractional flow reserve, fluxo de reserva coronária e resistência microvascular) e de vasoreatividade em todos os doentes. Vinte doentes foram incluídos, a média de idade foi de 63±13 anos e 50% eram do sexo feminino. A maioria dos doentes apresentava angina persistente e evidência de isquemia em teste não invasivo (75%). O EFC foi bem-sucedido em todos os doentes e não se verificaram complicações major. A AMV foi diagnosticada em 25%, a AV em 40%, AMV e VSA em simultâneo em 10% e dor torácica não cardíaca em 25% dos doentes. Houve necessidade de modificação da terapêutica antianginosa após os resultados do EFC em 70% dos doentes. O EFC demonstrou ser exequível e seguro numa população de doentes com ANOCA. Os DVC foram prevalentes nesse grupo selecionado e uma proporção de doentes apresentou simultaneamente diferentes fenótipos de DVC. O EFC possibilita um diagnóstico definitivo a doentes com ANOCA, permite o ajuste da terapêutica farmacológica.
No takes yet. Share an insight, caveat, or question.
Ramos et al. (2023) conducted an observational in Angina and non-obstructive coronary artery disease (ANOCA) (n=20). Comprehensive coronary function test (CFT) protocol was evaluated on Safety, feasibility, and prevalence of different phenotypes of coronary vasomotion disorders. A comprehensive coronary function test protocol was feasible and safe in patients with ANOCA, identifying isolated microvascular angina in 25% and isolated vasospastic angina in 40%.
Synapse has enriched 10 related papers. Consider them for comparative context: